Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy of STAHIST in Seasonal Allergic Rhinitis
NCT01293201Phase 3Completed
- Sponsor
- Magna Pharmaceuticals
- Start
- Mar 2011
- Primary completion
- Jun 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of pseudoephedrine + chlorpheniramine + atropine in seasonal allergic rhinitis (SAR), sponsored by Magna Pharmaceuticals. Started Mar 2011; status: completed.
02
Drugs
pseudoephedrine + chlorpheniramine + atropine
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NCT01293201.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01293201.